icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
High Efficacy in Patients With Chronic Hepatitis C Virus (HCV) Genotype 1b Infection Treated with Elbasvir/Grazoprevir for 12 Weeks: An Integrated Analysis
 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Zeuzem S1; Serfaty L2; Vierling JM3; Cheng W4; George J5; Sperl J6; Strasser S7; Kumada H8; Hwang P9; Robertson M9; Wahl J9; Barr E9; Talwani R9; Platt H9
1Goethe University Hospital, Frankfurt, Germany; 2Université Pierre & Marie Curie, Paris, France; 3Baylor College of Medicine, Baylor-St. Luke's Medical Center, Houston, TX, USA; 4Royal Perth Hospital, Perth, WA, Australia; 5University of Sydney, Sydney, NSW, Australia; 6Institut Klinické a Experimentální Medicíny (IKEM), Prague, Czech Republic; 7AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia; 8Department of Hepatology, Toranomon Hospital, Tokyo, Japan; 9Merck & Co., Inc., Kenilworth, NJ, USA.

HIV1

HIV2

HIV3

HIV4

HIV5

HIV6